NASDAQ Equity Snapshot
CRBU Weekly Equity Report
Caribou Biosciences Inc
What the company does
Caribou Biosciences Inc. is a pioneering biotechnology firm specializing in cutting-edge genome editing technologies, particularly through its proprietary CRISPR platform. With a robust and diversified pipeline of innovative product candidates aimed at tackling urgent unmet medical needs in genetic disorders and oncology, the company is well-positioned to lead advancements in precision medicine. Leveraging strategic partnerships and a commitment to transformative research, Caribou aims to redefine treatment paradigms and significantly improve patient outcomes, establishing itself as a formidable entity in the biopharmaceutical sector.
What the weekly tape is saying
CRBU closed the latest completed week at 1.59 USD. The 4-week return is -25.5% and the 12-week return is -14.7%. Trend Signal is active, Market Dynamics is 0.56. Setup signature: Risk-first tape with a 25/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.82 USD
- Vs Trend Line
- -12.6%
- Fair Value
- 2.89 USD
- Vs Fair Value
- -44.8%
- 52W High
- 3.54 USD
- 52W Low
- 1.04 USD
- Drawdown
- -54.9%
- Range Position
- 22.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 4 weeks
- 52W Active Weeks
- 25
- 52W Active Breadth
- 48.1%
- Sector Scope
- US Healthcare
- Sector Rank
- 1002 of 1038
- Sector Percentile
- 3.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.56
- 4W MD Change
- -36.3%
- Relative Strength
- -28.44
- 4W RS Change
- -3572.3%
- Expectation
- Negative
- Probability
- 41.78%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 9.3M
- 13W Average
- 7.4M
- 52W Average
- 7.9M
- Vs 13W
- 1.2x
- Vs 52W
- 1.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.2%
- 52W Volatility
- 10.5%
- Upside Weeks
- 25
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 10.2% / -7.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 229.1M
Opportunity signals
- Trend Signal is active with a 4-week active streak.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.59 USD | -16.9% | 1.82 USD | 2.89 USD | 0.56 | -28.44 | 9.3M | On |
| 5 Jun 2026 | 1.92 USD | -18.6% | 1.84 USD | 2.91 USD | 1.01 | -11.82 | 9.3M | On |
| 29 May 2026 | 2.36 USD | 12.4% | 1.84 USD | 2.92 USD | 1.07 | 3.72 | 8.6M | On |
| 22 May 2026 | 2.10 USD | -1.9% | 1.85 USD | 2.94 USD | 0.86 | -4.35 | 8.3M | On |
| 15 May 2026 | 2.14 USD | 10.3% | 1.86 USD | 2.95 USD | 0.87 | -0.77 | 10.7M | Off |
| 8 May 2026 | 1.94 USD | 3.7% | 1.87 USD | 2.97 USD | 0.84 | -9.65 | 5.8M | Off |
| 1 May 2026 | 1.87 USD | -12.2% | 1.89 USD | 2.98 USD | 0.84 | -7.45 | 6.7M | Off |
| 24 Apr 2026 | 2.13 USD | -3.2% | 1.91 USD | 3.00 USD | 0.87 | 7.72 | 8.7M | Off |
| 17 Apr 2026 | 2.20 USD | 14.0% | 1.91 USD | 3.01 USD | 0.66 | 14.99 | 9.6M | Off |
| 10 Apr 2026 | 1.93 USD | -0.5% | 1.89 USD | 3.03 USD | 0.50 | 8.34 | 4.4M | Off |
| 2 Apr 2026 | 1.94 USD | 9.0% | 1.89 USD | 3.05 USD | 0.48 | 14.68 | 5.2M | Off |
| 27 Mar 2026 | 1.78 USD | -4.8% | 1.88 USD | 3.07 USD | 0.38 | 10.51 | 4.4M | Off |
| 20 Mar 2026 | 1.87 USD | -0.5% | 1.89 USD | 3.09 USD | 0.47 | 13.23 | 5.8M | Off |
| 13 Mar 2026 | 1.88 USD | 3.3% | 1.89 USD | 3.11 USD | 0.32 | 12.39 | 6.4M | Off |